Chemical Structure : Givinostat
CAS No.: 497833-27-9
货号: PC-22791Not For Human Use, Lab Use Only.
Givinostat (ITF-2357) is a potent, orally active, pan-HDAC inhibitor with IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively.
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 5 mg | ¥780 | In stock | |
| 10 mg | ¥1180 | In stock | |
| 25 mg | ¥2180 | In stock | |
| 50 mg | ¥3580 | In stock | |
| 100 mg | Get quote | 
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
	Givinostat (ITF-2357) is a potent, orally active, pan-HDAC inhibitor with IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively.
	Givinostat (ITF-2357) has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cells.
	Givinostat (ITF-2357) reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivo.
	Givinostat (ITF-2357) reduces cytokines and protects islet β cells in vivo and in vitro.
| 分子量 | 421.50 | |
| 分子式 | C24H27N3O4 | |
| 外观性状 | Solid | |
| 储存条件 | 
                            
  | 
                        
                            
  | 
                    
| Solubility | 
                             10 mM in DMSO  | 
                    |
| Chemical Name/SMILES | 
                             (6-((diethylamino)methyl)naphthalen-2-yl)methyl (4-(hydroxycarbamoyl)phenyl)carbamate  | 
                    |
1. Li S, et al. J Biol Chem. 2015 Jan 23;290(4):2368-78.
2. Leoni F, et al. Mol Med. 2005 Jan-Dec;11(1-12):1-15.
3. Golay J, et al. Leukemia. 2007 Sep;21(9):1892-900.
4. Guerini V, et al. Leukemia. 2008 Apr;22(4):740-7.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright